Camena
A synthetic biology company that developed a technology that overcomes these limitations by using a wholly novel enzymatic technology to accurately produce synthetic DNA
Camena has raised €9.2M across 1 funding round from 1 investor, most recently a Series A round in Jul 2023. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.camenabio.com ↗
Total raised
€9.2M
€9,200,000
Funding rounds
1
Investors
1
distinct backers
Active since
2023-07
latest 2023-07
Funding by year
EUR raised per yearCamena — funding by year — interactive chart.
Data table
| Camena — funding by year | |
|---|---|
| 2023 | €9.2M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-07-03 | Series A | €9.2M | Mercia Ventures | View deal → |